Myopia Trends in Europe: A Reappraisal of Current Evidence Authors: Carla Lanca, Ian Morgan, Andrzej Grzybowski Published: 2026 ABSTRACT Our commentary critically examines whether the widely accepted projection of a global myopia epidemic, most prominently proposed by Holden et al. (2016), adequately reflects the European context. These projections assume that most regions outside Africa and Oceania will follow an East Asian-type trajectory, implying that Western populations with prolonged formal education are on a similar path. By reviewing recent European epidemiological evidence, including meta-analyses, we highlight that myopia prevalence in European young adults remains approximately 20–30%, substantially lower than the 70–90% levels reported in East Asia. We further examine how differences in educational systems, lifestyle patterns, and environmental exposures, particularly time spent outdoors, may contribute to this divergence. Importantly, this commentary evaluates the extent to which methodological factors influence reported prevalence, particularly in pediatric populations where most epidemiological data are generated. Variation in age structure, sampling strategies, and especially the use of non-cycloplegic refraction can inflate prevalence estimates and contribute to the perception of increasing trends. When analyses are restricted to comparable age groups and cycloplegic data, evidence for a substantial temporal increase in Europe becomes less consistent. Through this analysis, we question whether current global projections may overestimate future risk in Europe by extrapolating from fundamentally different populations. Finally, we propose that monitoring strategies combining pragmatic school-based screening with standardized cycloplegic assessment may provide a more accurate and context-specific understanding of trends. Overall, this commentary suggests that a myopia epidemic is not inevitable and that Europe represents a critical test case for understanding how environmental, educational, and cultural factors shape myopia development. Key Summary Points Global projections of myopia prevalence assume that Europe will follow an East Asian-type trajectory, but this may not reflect regional realities.Current European evidence indicates that myopia prevalence in young adults remains substantially lower than in East Asia.Apparent increases in European myopia prevalence are strongly influenced by methodological factors, particularly age structure and the use of non-cycloplegic refraction.Differences in educational systems, lifestyle, and outdoor exposure may explain why Europe has not experienced a similar epidemic pattern.Europe represents a critical test case, suggesting that a myopia epidemic is not inevitable and may depend on modifiable environmental and cultural factors. Global projections of myopia prevalence assume that Europe will follow an East Asian-type trajectory, but this may not reflect regional realities.Current European evidence indicates that myopia prevalence in young adults remains substantially lower than in East Asia.Apparent increases in European myopia prevalence are strongly influenced by methodological factors, particularly age structure and the use of non-cycloplegic refraction.Differences in educational systems, lifestyle, and outdoor exposure may explain why Europe has not experienced a similar epidemic pattern.Europe represents a critical test case, suggesting that a myopia epidemic is not inevitable and may depend on modifiable environmental and cultural factors. Is Myopia Increasing Everywhere? Global projections, such as those published by Holden et al. in 2016, suggest a substantial rise in myopia worldwide by 2050, particularly in high-income Asian regions [1]. These estimates have shaped the perception that myopia is increasing uniformly across all populations. Those projections, based on data from more than 2 million participants, correctly raised international concern and helped mobilize prevention and control efforts. Yet, they also encouraged a perception that every region, Europe included, was following East Asia’s trajectory. As a result, projections and concerns derived largely from East Asian populations are frequently extrapolated to the European context in clinical discussions, educational material, and general ophthalmology literature. While these distinctions are well recognized within epidemiological research, they are less frequently discussed in the broader clinical ophthalmology literature. This Perspective was therefore motivated by the need to provide a concise and clinically accessible overview of the current European evidence and its methodological context. Current evidence from European population studies suggests a different epidemiological pattern. While myopia is common, the overall prevalence across Europe remains moderate and relatively stable, and apparent increases often reflect methodological differences, especially the use of non-cycloplegic refraction, rather than true epidemiological change. Recent systematic reviews and meta-analysis of European populations provide evidence supporting this observation [2, 3]. Europe’s epidemiological curve appears flatter and its distribution more heterogeneous than previous global projections suggest. Myopia in Europe The global conversation on myopia often centers on East Asia, where prevalence among young adults exceeds 80% [4]. Europe, however, appears to follow a different historical trajectory. Evidence suggests that myopia prevalence in Europe has risen slowly over more than a century, broadly mirroring the expansion of compulsory education and the increasing proportion of children completing secondary schooling. Early observations, such as Cohn’s reports of high myopia rates among students in the senior school years, did not translate into high population prevalence, a pattern later clarified by Parssinen, who also noted that educational reforms promoting more balanced curricula and time outdoors helped moderate further increases [5]. This long-term, gradual rise contrasts sharply with the rapid escalation seen in East Asia, where deeply rooted educational cultures, high academic pressure, intensive tutoring, and limited outdoor time have driven prevalence towards 80% by the end of schooling. From this perspective, the scope for further dramatic increases in European myopia prevalence is limited unless the continent were to adopt similarly intensive educational models. Findings from new meta-analysis of population- and school-based studies report pooled myopia prevalence estimates in the range of 23.5% to 24.9%, confirming that myopia remains less common in Europe than in Asia but also reveals considerable variability between countries and study methods [2, 3]. Crucially, the method used to assess refractive error has a substantial impact on prevalence estimates. In a recent European meta-analysis, prevalence was markedly lower when restricted to studies using cycloplegic refraction (the gold standard for accurate diagnosis) compared with non-cycloplegic methods (18.9% vs. 31.2%; Fig. 1A). This difference highlights how methodological inconsistencies often drive perceived increases in prevalence. Importantly, this pattern is reinforced by another recent European meta-analysis, which also report lower prevalence estimates when cycloplegic measurements are used, although the magnitude of the difference varied between studies [3]. Together, these findings across independent and contemporary syntheses highlight how methodological inconsistencies can influence reported prevalence and complicate comparisons across studies and over time. This systematic inflation of prevalence estimates aligns with the experience from large European datasets such as Williams et al., whose analysis is based on non-cycloplegic refractions and therefore may reflect a methodological overestimate rather than true epidemiological change [6]. Taken together, these results underscore that much of the apparent rise in European myopia prevalence may be attributable to measurement inconsistency rather than genuine shifts in underlying population risk.Fig. 1Myopia prevalence in Europe by diagnostic method, age group, and country. A Pooled prevalence of myopia across all included studies (23.5%), compared with estimates from cycloplegic-only studies (18.9%) and non-cycloplegic studies (31.2%). B Age-specific prevalence from cycloplegic studies, showing substantially lower prevalence in children aged 6–11 years (5.5%) compared with adolescents (25.2%) and young adults (24.3%). C Country-level pooled prevalence estimates, annotated by study age range and diagnostic method. Substantial variation is observed across countries (11.9% in Finland to 49.7% in Sweden). However, these estimates are derived from studies with different age distributions and refraction methods and therefore do not represent directly comparable or age-standardized national prevalence. Error bars represent 95% confidence intervals.Data source: Moreira-Rosário A, Lanca C, Grzybowski A. Prevalence of myopia in Europe: a systematic review and meta-analysis of data from 14 countries. The Lancet Regional Health—Europe. 2025; 101319. https://doi.org/10.1016/j.lanepe.2025.101319 Myopia prevalence in Europe by diagnostic method, age group, and country. A Pooled prevalence of myopia across all included studies (23.5%), compared with estimates from cycloplegic-only studies (18.9%) and non-cycloplegic studies (31.2%). B Age-specific prevalence from cycloplegic studies, showing substantially lower prevalence in children aged 6–11 years (5.5%) compared with adolescents (25.2%) and young adults (24.3%). C Country-level pooled prevalence estimates, annotated by study age range and diagnostic method. Substantial variation is observed across countries (11.9% in Finland to 49.7% in Sweden). However, these estimates are derived from studies with different age distributions and refraction methods and therefore do not represent directly comparable or age-standardized national prevalence. Error bars represent 95% confidence intervals. Data source: Moreira-Rosário A, Lanca C, Grzybowski A. Prevalence of myopia in Europe: a systematic review and meta-analysis of data from 14 countries. The Lancet Regional Health—Europe. 2025; 101319. https://doi.org/10.1016/j.lanepe.2025.101319 Variability Across Europe: Age, Educational Exposure, and Methodology Considerable variation in reported myopia prevalence across European countries is illustrated in Fig. 1C, with estimates ranging from 11.9% in Finland to 49.7% in Sweden [2]. However, these estimates were not age-standardized and were derived from studies with markedly different age ranges, sampling strategies, and refraction methods, limiting direct comparability between countries. In particular, the age composition of study populations varied substantially across the included data. For example, the estimate from Sweden was based on a narrow adolescent sample assessed under cycloplegia (12–13 years), whereas estimates from Hungary and Germany were derived from broad adult populations assessed without cycloplegia (18–99 and 35–79 years, respectively). A substantial proportion of the apparent between-country variation likely reflects differences in population age structure and study methodology, rather than true geographic differences in myopia prevalence. At a regional level, pooled prevalence estimates seem to be broadly similar across Europe, generally falling within the range of approximately 20–26% across Northern, Eastern, Western, and Southern regions, with some higher values reported in Central and Southeast Europe [2, 3]. However, these differences should be interpreted with caution, as they are accompanied by extremely high heterogeneity (I2 ~ 99–100%) and wide prediction intervals, indicating substantial variability within regions. Given the strong age dependence of myopia prevalence, these differences are likely to have a major influence on the observed estimates. The most influential factor seems to be the age or school grade of participants, which is effectively a proxy for cumulative exposure to education. This is clearly illustrated in Fig. 1B, where prevalence increases from approximately 5.5% in children aged 6–11 years to 25.2% in adolescents (12–17 years), remaining at a similar level in young adults (18–39 years) [2]. This age-related pattern is broadly supported by other recent European meta-analyses, although absolute estimates vary according to age grouping, study design, and refraction method. Pediatric-focused analyses report low pooled prevalence in early childhood, increasing from approximately 6.2% in children aged 4–9 years to 16.4% in those aged 10–13 years and 16.7% in the ≥ 14 age group [7]. Similarly, pooled prevalence across children aged 0–18 years (mean age ~ 8 years) was estimated at approximately 7.2% [8]. Broader age-stratified analyses reported higher pooled estimates, rising from 15.6% in children aged 6–10 years to 25.0% in adolescents aged 11–15 years, 29.0% at 16–20 years, and 33.4% in adults older than 20 years [3]. However, these estimates are accompanied by substantial heterogeneity across studies (I2 typically ~ 99–100%), reflecting marked differences in population characteristics, age distributions, sampling strategies, and measurement methods. As a result, pooled estimates within age groups often encompass wide ranges, and differences between age categories should be interpreted with caution. In this context, the apparent similarity between adolescents and young adults observed in Fig. 1B should not be generalized across all studies. While some analyses suggest a continued increase into adulthood, the high heterogeneity and lack of age standardization limit direct comparisons between age groups and across studies. A growing body of evidence indicates that a substantial proportion of myopia onset occurs after the age of 18 years [9, 10], which may not be adequately reflected in cross-sectional prevalence estimates that combine individuals with differing educational exposure and refractive histories. Overall, despite variability in absolute estimates, the consistency of the age-related gradient across meta-analyses indicates that myopia prevalence increases with age, particularly during the school years. This supports the view that cumulative educational exposure is a key contributing factor. Several studies, including reviews by Brennan et al., emphasize that children who do not attend school rarely develop myopia [11]. The challenge, therefore, is not to reduce education but to ensure that schooling is compatible with healthy visual development. Across contemporary European meta-analyses, no consistent differences in myopia prevalence were observed between males and females, and urban versus rural residence does not appear to be a strong or reliable predictor once study heterogeneity is considered [2, 3]. This pattern is consistent across multiple analyses, despite substantial variability between studies, suggesting that these factors do not explain the wide differences in reported prevalence across Europe. This apparent lack of urban–rural disparity may reflect the increasing convergence of lifestyles across Europe, where intensive educational demands, screen-based activities, and reduced outdoor time are no longer confined to urban environments. However, this interpretation should be treated with caution, as most studies did not measure behavioral exposures, such as outdoor time, near work, or screen use, in a standardized way, limiting the ability to directly link lifestyle factors to prevalence patterns. Time outdoors appears to be a critical protective factor. Landmark studies by Rose et al. and Jones et al. demonstrated that higher outdoor exposure substantially reduces the onset of myopia, even among children with significant near-work demands [12, 13]. Although educational intensity is increasing worldwide, European children typically spend more time outdoors on weekends and during school holidays, whereas children in many East Asian settings often spend less time outdoors during these same periods because of tutoring and academic pressure. Methodological factors further exaggerate apparent differences between countries, particularly variations in study design, sampling strategies, and the use, or omission, of cycloplegic refraction. Indeed, what appears to be a temporal rise in myopia between 2000–2010 and 2011–2022 disappears once analyses are age-adjusted and limited to cycloplegic data [2], indicating that Europe’s myopia burden has been relatively stable within comparable age groups. Mixed Trends in Europe Several studies indicate stable or low rates of myopia in parts of Northern and Central Europe, particularly in childhood. However, these findings should be interpreted cautiously, as they are derived from studies with important methodological limitations. For example, in Sweden, a retrospective analysis of medical records in children aged 4–7 years reported low and stable prevalence (0.5–1.2% over 5 years) [14]. Similarly, longitudinal data from Swedish schoolchildren aged 8–16 years reported a low cumulative incidence [15], although the study may have been underpowered to detect changes over time. Evidence from adult or conscript populations also suggests relative stability. In Finland, a recent cycloplegic study of conscripts reported a prevalence of 23.5%, comparable to earlier cohorts [16], while Swiss conscript data showed little change over time [17]. However, such estimates are based on selected populations and may not reflect broader population trends. Likewise, long-term Danish data found no consistent increase in myopia prevalence [18], although substantial heterogeneity in methodology, including differences in refraction protocols, definitions of myopia, and sampling strategies, limits comparability across studies. Not all European data indicate stability. Historical Swedish conscript data reported increases in myopia prevalence and high myopia over time [19], with associations to educational attainment. However, these findings are also subject to methodological constraints, as refractive status was largely derived from spectacle prescriptions or non-cycloplegic manual subjective refraction. More recent cohort data from the Netherlands provide further evidence of generational effects, demonstrating higher prevalence in more recent birth cohorts and strong associations with educational exposure and urban lifestyle factors [20]. Importantly, these findings are derived from studies using relatively consistent methodology within a single population, allowing clearer detection of temporal trends compared with cross-study comparisons. Taken together, the European literature does not provide a consistent or directly comparable picture of temporal trends. Instead, much of the apparent variation, both between studies and over time, likely reflects differences in study design, population structure, and measurement methods, rather than clear epidemiological shifts in myopia prevalence. As illustrated in Fig. 2, a decision framework can be used to interpret reported prevalence considering key methodological factors, including age structure, refraction method, and sampling structure.Fig. 2Interpreting reported myopia prevalence in Europe. Reported prevalence varies with age structure, refraction method, and sampling design. Differences between studies may reflect methodological factors as much as true epidemiological variation Interpreting reported myopia prevalence in Europe. Reported prevalence varies with age structure, refraction method, and sampling design. Differences between studies may reflect methodological factors as much as true epidemiological variation A Call for Standardization and Surveillance There is an urgent need for a unified European approach to studying and monitoring myopia. Consistent use of cycloplegic refraction should become standard practice to ensure diagnostic accuracy, and data should be systematically reported by age and sex to enable valid cross-country comparisons. However, we cannot afford to delay action while waiting for ideal data systems to be established. In countries where school screening programs already exist, visual acuity data, particularly from students in the senior school years, can provide a close and timely approximation of myopia prevalence when collected and analyzed properly. Building on these existing infrastructures, while progressively moving toward more standardized, cycloplegic, and population-level measurements, will allow Europe to detect emerging trends early and guide effective public health strategies. Reliable, standardized, and pragmatically gathered data are essential to inform prevention, education, and policy initiatives across the continent. Conclusions Although myopia prevalence in Europe remains relatively modest, this should not lead to complacency. Protecting Europe’s comparatively lower prevalence requires proactive, coordinated action. Increasing children’s time outdoors, implementing early vision screening in schools, and embedding myopia management within primary healthcare systems remain practical, cost-effective strategies aligned with the World Health Organization’s vision health initiatives. At the same time, robust surveillance is critical. While the long-term goal should be a unified European approach using cycloplegic refraction with consistent age-stratified reporting, relying solely on such ideal systems risks delaying essential care. A pragmatic interim solution is the systematic screening of representative samples of senior high school students using visual acuity testing. When conducted properly, this approach provides a rapid, scalable, and reliable approximation of myopia prevalence and could be readily coordinated through European ophthalmology networks. This would allow Europe to detect emerging trends quickly, while more precise surveillance infrastructures are built. Taken together, these strategies offer a balanced path forward: immediate, actionable monitoring through school-based visual acuity screening, coupled with the gradual establishment of standardized cycloplegic surveillance. Maintaining methodological rigor while embracing practical solutions will be essential to safeguard Europe’s visual health and guide evidence-based public health planning.